Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Anti-Neutrophil Cytoplasmic Antibody - Associated Vasculitis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ...

SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally ...

Please provide your email address to receive an email when new articles are posted on . “Today is a momentous day in the history of ChemoCentryx; the culmination of decades of effort aimed at offering ...

Doctor talking to cancer patient A EULAR task force revised guidelines to reflect findings from randomized clinical trials that were published since the last update in 2016. A task force of the ...

The patient in the current case report showed manifestations of both AAV and IgG4-RD; his improvement linked to steroid/cyclophosphamide treatment underscores the need for integrated diagnosis and ...

Please provide your email address to receive an email when new articles are posted on . Cigarette smoking was associated with ANCA-associated vasculitis, particularly myeloperoxidase ANCA-positive ...

San Antonio, TX - Rituximab (Rituxan, Genentech) also holds promise in the treatment of severe antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis in addition to rheumatoid arthritis ...

Maintaining remission in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis who have kept their autoantibodies in check after at least 2 years on rituximab therapy has ...

Bronchiectasis is a common pulmonary feature among a subset of patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis, French researchers reported. The ANCA-associated ...

"ANCA Vasculitis Pipeline 2025"DelveInsight's,“ANCA Vasculitis - Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline ...

Small-vessel vasculitic syndromes such as Wegener granulomatosis and microscopic polyangiitis, which are associated with circulating antineutrophil cytoplasmic autoantibodies, are an important cause ...

Wegener's granulomatosis, microscopic polyangiitis (MPA), Churg–Strauss syndrome, and primary pauci-immune crescentic glomerulonephritis are associated with circulating anti-neutrophil cytoplasmic ...